Publication | Open Access
A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis
15
Citations
14
References
2024
Year
Our 4-BRG signature has the potential as an independent biomarker for predicting prognosis and treatment response in BRCA patients, complementing existing clinicopathological characteristics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1